Vimarsana
Biggest News Aggregation in the World

Vascular Outcomes Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vascular Outcomes Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vascular Outcomes Study Today - Breaking & Trending Today

ACC: VOYAGER-PAD Makes Case for Rivaroxaban | Physician's Weekly - Vimarsana News

ACC: VOYAGER-PAD Makes Case for Rivaroxaban | Physician's Weekly

Jan 1, 2021 But if rivaroxaban is ’in’, is DAPT ’out’? The introduction of direct oral anticoagulants (DOACs) in 2010 significantly changed clinical algorithms for prevention of VTE and stroke, as well as management of atrial fibrillation. In this report, which was initially published March 29, 2020, researchers presented findings that support a role for rivaroxaban in revascularization procedures in patients with PAD. BreakingMED is republishing this report as part of its year end clinical review series. Findings from a trial of more than 6,564 patients undergoing revascularization ...